Angelo LS - Search Results

1

A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R) : implications for inhibition of the IGF-1R signal.

Janku F, Huang HJ, Angelo LS, Kurzrock R. Janku F, et al. Among authors: angelo ls. Oncotarget. 2013 Mar;4(3):463-73. doi: 10.18632/oncotarget.886. Oncotarget. 2013. PMID: 23531874 Free PMC article.

2

R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.

Huang HJ, Angelo LS, Rodon J, Sun M, Kuenkele KP, Parsons HA, Trent JC, Kurzrock R. Huang HJ, et al. Among authors: angelo ls. PLoS One. 2011;6(10):e26060. doi: 10.1371/journal.pone.0026060. Epub 2011 Oct 11. PLoS One. 2011. PMID: 22022506 Free PMC article.

3

Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications.

Jiang Y, Janku F, Subbiah V, Angelo LS, Naing A, Anderson PM, Herzog CE, Fu S, Benjamin RS, Kurzrock R. Jiang Y, et al. Among authors: angelo ls. Oncotarget. 2013 Jun;4(6):884-9. doi: 10.18632/oncotarget.1021. Oncotarget. 2013. PMID: 23800680 Free PMC article.

4

NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations.

Schroeder RD, Angelo LS, Kurzrock R. Schroeder RD, et al. Among authors: angelo ls. Oncotarget. 2014 Jan 15;5(1):67-77. doi: 10.18632/oncotarget.1557. Oncotarget. 2014. PMID: 24393766 Free PMC article. Review.

5

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab.

Falchook GS, Wheler JJ, Naing A, Jackson EF, Janku F, Hong D, Ng CS, Tannir NM, Lawhorn KN, Huang M, Angelo LS, Vishwamitra D, Hess K, Howard AN, Parkhurst KL, Amin HM, Kurzrock R. Falchook GS, et al. Among authors: angelo ls. Oncotarget. 2014 Nov 15;5(21):10280-92. doi: 10.18632/oncotarget.2163. Oncotarget. 2014. PMID: 25373733 Free PMC article. Clinical Trial.

6

Vascular endothelial growth factor and its relationship to inflammatory mediators.

Angelo LS, Kurzrock R. Angelo LS, et al. Clin Cancer Res. 2007 May 15;13(10):2825-30. doi: 10.1158/1078-0432.CCR-06-2416. Clin Cancer Res. 2007. PMID: 17504979 Review.

7

Interleukin-6 and its receptor in cancer: implications for translational therapeutics.

Hong DS, Angelo LS, Kurzrock R. Hong DS, et al. Among authors: angelo ls. Cancer. 2007 Nov 1;110(9):1911-28. doi: 10.1002/cncr.22999. Cancer. 2007. PMID: 17849470 Free article. Review.

8

Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia.

Angelo LS, Kurzrock R. Angelo LS, et al. Clin Cancer Res. 2009 Feb 15;15(4):1123-5. doi: 10.1158/1078-0432.CCR-08-2791. Clin Cancer Res. 2009. PMID: 19228716 Free PMC article.

9

Molecular imaging of gefitinib activity in an epidermal growth factor receptor (EGFR)-bearing xenograft model.

Gong J, Yang DJ, Kohanim S, Angelo LS, Kurzrock R. Gong J, et al. Among authors: angelo ls. Cancer Biol Ther. 2009 Dec;8(23):2239-47. doi: 10.4161/cbt.8.23.9986. Epub 2009 Dec 2. Cancer Biol Ther. 2009. PMID: 19823028 Free article.

10

Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways.

Angelo LS, Wu JY, Meng F, Sun M, Kopetz S, McCutcheon IE, Slopis JM, Kurzrock R. Angelo LS, et al. Mol Cancer Ther. 2011 Nov;10(11):2094-103. doi: 10.1158/1535-7163.MCT-11-0243. Epub 2011 Sep 8. Mol Cancer Ther. 2011. PMID: 21903608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters